These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9670209)

  • 1. Angiotensin-converting enzyme inhibition attenuates proteinuria and renal TGF-beta 1 mRNA expression in rats with chronic renal disease.
    Ali SM; Laping NJ; Fredrickson TA; Contino LC; Olson Ba; Anderson K; Brooks DP
    Pharmacology; 1998 Jul; 57(1):20-7. PubMed ID: 9670209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angiotensin-converting enzyme inhibition alters clusterin mRNA expression in the kidney following renal mass reduction.
    Olson BA; Ali SM; Contino LC; Brooks DP; Laping NJ
    Pharmacology; 1998 Jul; 57(1):13-9. PubMed ID: 9670208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A
    Ann Acad Med Stetin; 1999; Suppl 52():1-93. PubMed ID: 10589103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related increase in expression of TGF-beta1 in the rat kidney: relationship to morphologic changes.
    Ruiz-Torres MP; Bosch RJ; O'Valle F; Del Moral RG; Ramírez C; Masseroli M; Pérez-Caballero C; Iglesias MC; Rodríguez-Puyol M; Rodríguez-Puyol D
    J Am Soc Nephrol; 1998 May; 9(5):782-91. PubMed ID: 9596075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ACE inhibitor reduces Th2 cytokines and TGF-beta1 and TGF-beta2 isoforms in murine lupus nephritis.
    De Albuquerque DA; Saxena V; Adams DE; Boivin GP; Brunner HI; Witte DP; Singh RR
    Kidney Int; 2004 Mar; 65(3):846-59. PubMed ID: 14871404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary transforming growth factor-beta (TGF-beta) excretion and renal production of TGF-beta in rats with subtotal renal ablation: effect of enalapril and nifedipine.
    Monteiro de Freitas AS; Coimbra TM; Costa RS; Baroni EA
    Nephron; 1998; 78(3):302-9. PubMed ID: 9546691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologic control of angiotensin II ameliorates renal disease while reducing renal TGF-beta in experimental mesangioproliferative glomerulonephritis.
    Zoja C; Abbate M; Corna D; Capitanio M; Donadelli R; Bruzzi I; Oldroyd S; Benigni A; Remuzzi G
    Am J Kidney Dis; 1998 Mar; 31(3):453-63. PubMed ID: 9506682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imidapril inhibits increased transforming growth factor-beta1 expression in remnant kidney model.
    Hamaguchi A; Kim S; Wanibuchi H; Iwao H
    Eur J Pharmacol; 1997 Jul; 331(1):27-30. PubMed ID: 9274926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renoprotective properties of pirfenidone in subtotally nephrectomized rats.
    Takakuta K; Fujimori A; Chikanishi T; Tanokura A; Iwatsuki Y; Yamamoto M; Nakajima H; Okada M; Itoh H
    Eur J Pharmacol; 2010 Mar; 629(1-3):118-24. PubMed ID: 20006961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangioproliferative glomerulonephritis.
    Nakamura T; Obata J; Kimura H; Ohno S; Yoshida Y; Kawachi H; Shimizu F
    Kidney Int; 1999 Mar; 55(3):877-89. PubMed ID: 10027924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Captopril enhances transforming growth factor (TGF)-beta1 expression in peripheral blood mononuclear cells: a mechanism independent from angiotensin converting enzyme inhibition? A study in cyclosporine-treated kidney-transplanted patients.
    Di Paolo S; Schena A; Stallone G; Grandaliano G; Soccio M; Cerullo G; Gesualdo L; Paolo Schena F
    Transplantation; 2002 Dec; 74(12):1710-5. PubMed ID: 12499886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renin angiotensin system blockade ameliorates lead nephropathy.
    Ng HY; Tain YL; Lee YT; Hsu CY; Chiou TT; Huang PC; Lee CT
    Biochem Biophys Res Commun; 2013 Aug; 438(2):359-63. PubMed ID: 23896603
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury.
    Tolins JP; Raij L
    Hypertension; 1990 Oct; 16(4):452-61. PubMed ID: 2210813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of angiotensin-converting enzyme inhibition on growth factor mRNA in chronic renal allograft rejection in the rat.
    Szabo A; Lutz J; Schleimer K; Antus B; Hamar P; Philipp T; Heemann U
    Kidney Int; 2000 Mar; 57(3):982-91. PubMed ID: 10720951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ACE inhibition modulates transforming growth factor-beta receptors in the young rat.
    Kang NS; Yim HE; Bae IS; Choi JH; Choi BM; Yoo KH; Hong YS; Lee JW; Kim SK
    Pediatr Nephrol; 2003 Sep; 18(9):865-71. PubMed ID: 12883979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
    Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ
    J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutralization of transforming growth factor-beta attenuates hypertension and prevents renal injury in uremic rats.
    Lavoie P; Robitaille G; Agharazii M; Ledbetter S; Lebel M; Larivière R
    J Hypertens; 2005 Oct; 23(10):1895-903. PubMed ID: 16148614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms underlying renoprotection during renin-angiotensin system blockade.
    Taal MW; Chertow GM; Rennke HG; Gurnani A; Jiang T; Shahsafaei A; Troy JL; Brenner BM; Mackenzie HS
    Am J Physiol Renal Physiol; 2001 Feb; 280(2):F343-55. PubMed ID: 11208610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. AT1 antagonist modulates activin-like kinase 5 and TGF-beta receptor II in the developing kidney.
    Yim HE; Kim MK; Bae IS; Kim JH; Choi BM; Yoo KH; Hong YS; Lee JW
    Pediatr Nephrol; 2006 Oct; 21(10):1377-88. PubMed ID: 16897002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ACE inhibition reduces proteinuria, glomerular lesions and extracellular matrix production in a normotensive rat model of immune complex nephritis.
    Ruiz-Ortega M; González S; Serón D; Condom E; Bustos C; Largo R; González E; Ortiz A; Egido J
    Kidney Int; 1995 Dec; 48(6):1778-91. PubMed ID: 8587237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.